APA (7th ed.) Citation

Van Damme Pierre, Gothefors Leif, Matson David O, Koch Gary, Itzler Robbin, DiNubile Mark J, & Heaton Penny M. (2010). Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5). BMC.

Chicago Style (17th ed.) Citation

Van Damme Pierre, Gothefors Leif, Matson David O, Koch Gary, Itzler Robbin, DiNubile Mark J, and Heaton Penny M. Robustness of the Healthcare Utilization Results from the Rotavirus Efficacy and Safety Trial (REST) Evaluating the Human-bovine (WC3) Reassortant Pentavalent Rotavirus Vaccine (RV5). BMC, 2010.

MLA (9th ed.) Citation

Van Damme Pierre, et al. Robustness of the Healthcare Utilization Results from the Rotavirus Efficacy and Safety Trial (REST) Evaluating the Human-bovine (WC3) Reassortant Pentavalent Rotavirus Vaccine (RV5). BMC, 2010.